Mounjaro results, month by month

SURMOUNT-1 recorded an average loss of up to 21% of body weight over 72 weeks. Here is what that looks like as a real timeline, including the slow start nobody posts about.

Person in trainers walking down steps

Month 1: the quiet month

On 2.5 mg, most people notice appetite changes but modest scale movement, often 2 to 4% of body weight, sometimes less. This month exists to build tolerance. People who quit here quit before the medicine has started working.

Months 2 to 3: momentum

Stepping through 5 mg and 7.5 mg, weekly loss of 0.5 to 1 kg becomes typical. Clothes fit differently before the mirror shows it. This is also when protein habits matter most, the weight coming off includes muscle unless you defend it.

Months 4 to 6: the steep middle

The fastest phase. Most responders pass 10% of starting weight somewhere here. Expect one or two plateaus, brief stalls are part of the pattern, and our plateau guide covers what moves them.

Months 7 to 12: approaching the new normal

Loss slows as your body finds its new equilibrium. In SURMOUNT-1, the 15 mg arm averaged about 21% at week 72. The 10 mg arm about 19.5%. 5 mg about 15%. Around a third of people on the highest dose lost 25% or more.

Then the more important question arrives: how to keep it. That is what the maintenance phase is for.

Why results vary so much

Averages conceal a wide spread. Sleep, protein intake, movement, stress, other medicines, and plain biology all move the number. The fairest expectation: most people who stay on treatment and work the habits lose between 10 and 20% over a year. Your prescriber tracks your curve against this at every check-in.

The SURMOUNT-1 curve, simplified

Average body weight change over 72 weeks in the highest-dose arm of SURMOUNT-1 (tirzepatide 15 mg, with diet and activity support).

Weeks of treatment: share of the total loss achieved. Loss is fastest in the middle months and flattens as you approach your body's new set point.

Continue reading

Mounjaro KwikPen with box

Mounjaro plan from £139 a month

Weekly injection, tirzepatide. Price covers the medicine, prescriber review, monthly check-ins and tracked delivery.

See the Mounjaro plan

Check if treatment suits youFree health check. You pay nothing until a prescriber approves.

Check your eligibility

About this page

Written by
Able Clinic editorial team
Clinical review
Pharmacy team at Curb Healthcare Ltd, GPhC 9012581
Last reviewed

Each page is checked against the UK licence for the medicine. Read our editorial policy.

Sources

  1. NICE TA1026: tirzepatide for managing overweight and obesity
  2. SURMOUNT-1 trial, New England Journal of Medicine 2022
  3. Electronic medicines compendium: Mounjaro product information
  4. MHRA Yellow Card scheme
Check your eligibility